Complete resolution of posttransplant lymphoproliferative disorder (diffuse large B-cell lymphoma) with reduction of immunosuppressive therapy

Yonsei Medical Journal

Volumn 45, Issue 3, 2004, Pages 527-532

  Ryu, Han Jak ^a   Hahn, Jee Sook ^a   Kim, Yu Seun ^a   Park, Kiil ^a   Yang, Woo Ick ^a   Lee, Jong Doo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Immunosuppression; PTLD; Reduction; Resolution

Indexed keywords

ACICLOVIR; FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LARGE CELL LYMPHOMA; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY;

EID: 3543040009     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2004.45.3.527     Document Type: Article

References (16)

1. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Prob Surg 1988;25:367-472
2. Purtilo DT. Epstein-Barr virus-induced oncogenesis in immunodeficient individuals. Lancet 1980;1:300-3.
3. Hanto DW, Frizzera G, Gajl-Peczlaska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N Engl J Med 1982;306:913-8.
4. Hanto DW, Frizzera G, Gajl-Peczlaska KJ, Balfour HH Jr, Simmons RL, Najarian JS, et al. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative disease. Transplant Proc 1985;17:89-93.
5. Pirsch JD, Stratta RJ, Sollinger HW, Hafez GR, D'Alessandro AM, Kalayoglu M, et al. Treatment of severe Epstein-Barr virus induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation. Am J Med 1989;86:241-4.
6. Soler MJ, Puig JM, Mir M, Parrilla C, Pedro A, Salar S, et al. Posttransplant lymphoproliferative Disease: Treatment and outcome in renal transplant recipients. Tranplant Proc 2003;35:1709-13.
7. Basgoz N, Preiksaitis JK. Post-transplant lymphoproliferative disorder[review]. Infect Dis Clin North Am 1995;9:901-23.
8. Choi SH, Hahn JS, Kim YS, Park KI. Four cases of posttransplant lymphoproliferative disease following renal transplatation. J Korean Soc Transplant 2000; 14:101-8.
9. Loren AW, Porter DL, Stadtmauer EA, Tsai DE. Posttransplant lymphoproliferative disorder: a review. Bone Marrow Transplant 2003;31:145-55.
10. Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplantation 1999;68:1517-25.
11. Preiksaitis JK, Keay S. Diagnosis and management of posttransplant lymphoproliferative disorder in solidorgan transplant recipients. Clin Infect Dis 2001;33 Suppl 1:S38-46.
12. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, et al. Reversibility of lymphomas and lymphoproleferative lesions developing under cyclosporine-steroid therapy. Lancet 1984;1:584-7.
13. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttranplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
14. Bobey NA, Stewart DA, Woodman RC. Successful treatment of postransplant lymphoproliferative disorder in a renal transplant patient by autologous peripheral blood stem cell transplantation. Leuk Lymphoma 2002;43:2421-3.
15. Tsai DE, Hardy CL, Tomaszewski JE. Reduction in immunosuppression as initial therapy for posttranplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients. Tranplantation 2001;71:1076-88.
16. Opelz G, Henderson H. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-6.